As an example, a reported genetically-engineered S. Typhimurium aroA aroD double mutant harboring the Flt3 Ligand, used to treat melanoma in mice resulted in 50% tumor regression (Yoon et al., 2007). This evidence concerns the gene LNCAROD and neoplasm.